side effects of stopping semaglutide abruptly Ozempic (semaglutide) is a GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its range from common GI symptoms to rare but serious risks. ⸻ 🟡 Common Semaglutide Side Effects Week by

Demand increased sharply as semaglutide and tirzepatide medications became associated with substantial weight loss, leading more patients without diabetes to use GLP-1 drugs

Still, tirzepatide also targets GIP (glucose-dependent insulinotropic peptide) receptors, potentially offering improved blood sugar control compared to Ozempic, which only targets GLP-1 receptors

For diabetes (Ozempic), the dosing starts at 0.25 mg weekly for four weeks, increases to 0.5 mg, and can go up to 1.0 mg or 2.0 mg depending on glycemic needs

We believe in personalization, not just prescriptions

doi:10.1053/j.gastro.2007.03.054 27